There will be a shareholder meeting on Dec. 4 to approve the transaction. The company hopes to complete the transaction swiftly after approval, but is still subject to customary closing conditions. There is no assurance on the ultimate timing of the proposed transaction and Symmetry Medical does not intend to provide regular updates on the progress.
However, there will be an announcement when the transaction is complete.
More articles on orthopedic devices:
Stryker hip implant settlement to exceed $1.4B—10 key facts
Orthopedic device market stock report—5 company updates
Alphatec Spine 3Q revenue up 2%: 10 key concepts
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
